These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

316 related articles for article (PubMed ID: 18580387)

  • 1. The effectiveness of guideline implementation strategies on improving antipsychotic medication management for schizophrenia.
    Owen RR; Hudson T; Thrush C; Thapa P; Armitage T; Landes RD
    Med Care; 2008 Jul; 46(7):686-91. PubMed ID: 18580387
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Prescribing patterns of antipsychotics in 13 French psychiatric hospitals].
    Bret P; Bret MC; Queuille E
    Encephale; 2009 Apr; 35(2):129-38. PubMed ID: 19393381
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The association between class of antipsychotic and rates of hospitalization: results of a retrospective analysis of data from the 2005 Medicare current beneficiary survey.
    Kennedy J; Tien YY; Cohen LJ; Sclar DA; Liu D; Blodgett EG; Engle J
    Clin Ther; 2009 Dec; 31(12):2931-9. PubMed ID: 20110033
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Randomized controlled trial of the effect on Quality of Life of second- vs first-generation antipsychotic drugs in schizophrenia: Cost Utility of the Latest Antipsychotic Drugs in Schizophrenia Study (CUtLASS 1).
    Jones PB; Barnes TR; Davies L; Dunn G; Lloyd H; Hayhurst KP; Murray RM; Markwick A; Lewis SW
    Arch Gen Psychiatry; 2006 Oct; 63(10):1079-87. PubMed ID: 17015810
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antipsychotic medication utilization trends among Texas veterans: 1997-2002.
    Yang M; Barner JC; Lawson KA; Rascati KL; Wilson JP; Crismon ML; Worchel J; Mascarenas CA
    Ann Pharmacother; 2008 Sep; 42(9):1229-38. PubMed ID: 18682544
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Benchmarking the quality of schizophrenia pharmacotherapy: a comparison of the Department of Veterans Affairs and the private sector.
    Leslie DL; Rosenheck RA
    J Ment Health Policy Econ; 2003 Sep; 6(3):113-21. PubMed ID: 14646004
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Associations between adherence to guidelines for antipsychotic dose and health status, side effects, and patient care experiences.
    Dickey B; Normand SL; Eisen S; Hermann R; Cleary P; Cortés D; Ware N
    Med Care; 2006 Sep; 44(9):827-34. PubMed ID: 16932134
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A meta-analysis of the efficacy of second-generation antipsychotics.
    Davis JM; Chen N; Glick ID
    Arch Gen Psychiatry; 2003 Jun; 60(6):553-64. PubMed ID: 12796218
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinicians' reasons for deviations from recommended dosing practices for antipsychotic medications.
    Sernyak MJ; Rosenheck R
    Adm Policy Ment Health; 2007 Nov; 34(6):540-7. PubMed ID: 17957463
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of first-generation antipsychotics versus second-generation antipsychotics on quality of life in schizophrenia: a double-blind, randomised study.
    Gründer G; Heinze M; Cordes J; Mühlbauer B; Juckel G; Schulz C; Rüther E; Timm J;
    Lancet Psychiatry; 2016 Aug; 3(8):717-729. PubMed ID: 27265548
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Factors related to antipsychotic oversupply among Central Texas Veterans.
    Yang M; Barner JC; Worchel J
    Clin Ther; 2007 Jun; 29(6):1214-25. PubMed ID: 17692735
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Guideline implementation and patient-tailoring strategies to improve medication adherence for schizophrenia.
    Hudson TJ; Owen RR; Thrush CR; Armitage TL; Thapa P
    J Clin Psychiatry; 2008 Jan; 69(1):74-80. PubMed ID: 18312040
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Facility-level factors influencing chronic heart failure care process performance in a national integrated health delivery system.
    Subramanian U; Sutherland J; McCoy KD; Welke KF; Vaughn TE; Doebbeling BN
    Med Care; 2007 Jan; 45(1):28-45. PubMed ID: 17279019
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oral antipsychotics for the treatment of schizophrenia: heterogeneity in efficacy and tolerability should drive decision-making.
    Volavka J; Citrome L
    Expert Opin Pharmacother; 2009 Aug; 10(12):1917-28. PubMed ID: 19558339
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of audit and feedback on antipsychotic prescribing in schizophrenia.
    Wheeler A; Humberstone V; Robinson E; Sheridan J; Joyce P
    J Eval Clin Pract; 2009 Jun; 15(3):441-50. PubMed ID: 19366393
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhancing multiyear guideline concordance for bipolar disorder through collaborative care.
    Bauer MS; Biswas K; Kilbourne AM
    Am J Psychiatry; 2009 Nov; 166(11):1244-50. PubMed ID: 19797436
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ethnic comparisons of antipsychotic use in schizophrenia.
    Wheeler A; Humberstone V; Robinson E
    Aust N Z J Psychiatry; 2008 Oct; 42(10):863-73. PubMed ID: 18777230
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Strategies for dosing and switching antipsychotics for optimal clinical management.
    Buckley PF; Correll CU
    J Clin Psychiatry; 2008; 69 Suppl 1():4-17. PubMed ID: 18484804
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Monitoring metabolic side effects when initiating treatment with second-generation antipsychotic medication.
    Weissman E; Jackson C; Schooler N; Goetz R; Essock S
    Clin Schizophr Relat Psychoses; 2012 Jan; 5(4):201-7. PubMed ID: 22182457
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predictors for starting depot administration of risperidone in chronic users of antipsychotics.
    Vehof J; Postma MJ; Bruggeman R; De Jong-Van Den Berg LT; Van Den Berg PB; Stolk RP; Burger H
    J Clin Psychopharmacol; 2008 Dec; 28(6):625-30. PubMed ID: 19011430
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.